SABS
SAB Biotherapeutics, Inc.
Set alert
3.35 USD +0.12 +3.72%
3.11 Day range 3.37
2.49 52-week range 4.59
- YTD
- -10.43%
- 1 year
- +11.30%
- Open
- 3.20
- Prev close
- 3.23
- Mkt cap
- 304.80M
- Vol
- 741.05K
- Avg vol
- 536.84K
- EPS
- -1.29
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.11
- High
- 3.37
- Forward P/E
- -1.56
- Beta
- 0.64
- Short ratio
- 1.22
- Inst. own
- 34.25%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 3.29
- 200-d avg
- 3.35
- 1y target
- 12.40
1Y chart
Closing price and volume
Compare SABS
Chart and line up SABS against other symbols or a saved comparison set.
- SABS SAB Biotherapeutics, Inc.
3.35
+0.12 +3.72%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | SABS | SPY | QQQ |
|---|---|---|---|
| Last price | 3.35 | 755.72 | 690.49 |
| Change | +0.12 | -13.64 | -24.85 |
| Change % | +3.72% | -1.77% | -3.47% |
| Open | 3.20 | 761.38 | 697.13 |
| Day high | 3.37 | 761.46 | 698.63 |
| Day low | 3.11 | 750.36 | 683.45 |
| Previous close | 3.23 | 769.36 | 715.34 |
| Volume | 741.05K | 77.70M | 85.24M |
| Average volume | 536.84K | 41.22M | 34.57M |
| Market cap | 304.80M | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -1.29 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 4.59 | 779.09 | 759.66 |
| 52-week low | 2.49 | 631.97 | 558.28 |
| 1-week return | +17.96% | -0.559233% | -1.97% |
| 1-month return | +5.68% | -0.906075% | -6.66% |
| 3-month return | -5.90% | +1.89% | +1.02% |
| 6-month return | -10.43% | +5.16% | +3.41% |
| Year-to-date return | -10.43% | +10.82% | +12.40% |
| 1-year return | +11.30% | +11.16% | +10.29% |
| 2-year return | +2.76% | +32.90% | +42.71% |
| 50-day moving average | 3.27 | 767.63 | 725.41 |
| 200-day moving average | 3.68 | 728.53 | 679.17 |
| Target price | 12.40 | — | — |
| Beta | 0.641 | 0.00 | 0.00 |
| Short ratio | 1.22 | — | — |
| Institutional ownership | 34.25% | — | — |